BMS, P&G tops for working mothers
December 1st 2001New York-based Bristol-Myers Squibb Co. and Cincinnati-based Procter & Gamble Co. made the top ten in Working Mother magazine's 16th annual list of the "100 Best Companies for Working Mothers," a compilation of corporations that best recognize the value and needs of working families.
Depression market poised to decline
December 1st 2001Despite the fact that the U.S. antidepressant market grew at a 20% annual rate between 1995 and 2000, the loss of patent exclusivity of selective serotonin reuptake inhibitors - beginning with Indianapolis-based Eli Lilly and Co.'s Prozac® (fluoxetine) last August - will likely cause the market for SSRIs and similar drugs to decline for the first time in over a decade, according to Decision Resources Inc., Waltham, MA. Also, novel therapies now under development for depression face greater challenges than previous treatments did.
HHS, Bayer agree to Cipro purchase
December 1st 2001In response to recent anthrax attacks on the media and the U.S. Senate, U.S. Health and Human Services and West Haven, CT-based Bayer Corp. have reached an agreement for a significant new federal purchase of the antibiotic Cipro™ (ciprofloxacin) at a substantially lowered price. The antibiotic is expected to be available by the end of 2001 and would be used to supplement existing emergency stockpiles for use in the event of a bioterrorist attack.
Rx marketing 'e-events' increasing
December 1st 2001The Internet has become a new meeting place for drug companies and doctors, according to the Physician Meeting and Event Audit from Newtown, PA-based Scott-Levin. From February through April 2001, Scott-Levin surveyed its PMEA panel every month to determine the extent of "e-event" activity. More than 3,100 physicians participated in the study; 39% indicated that they had been invited to at least one pharmaceutical company-sponsored event conducted via the Internet.
PhRMA finds 785 drugs in development for older Americans
December 1st 2001New medicines in the pipeline for Alzheimer's disease, osteoporosis, arthritis and Parkinson's disease are among the many promising treatments in development for diseases of aging, according to a new survey released by the Washington-based Pharmaceutical Research and Manufacturers of America.
U.S. trails behind in use of electronic records, prescribing
December 1st 2001Relatively small numbers of American physicians are using electronic records or prescribing, and the United States lags behind other English-speaking countries in this regard, according to a survey of physicians conducted by Rochester, NY-based Harris Interactive for the Harvard School of Public Health and the Commonwealth Fund's International Health Care Symposium in 2000. The survey found that the use of electronic systems is much more advanced in Britain, New Zealand and Australia than in the United States. The numbers for Canadian usage were low, however, similar to those in the United States.
Employees to share more healthcare costs
December 1st 2001Faced with double-digit healthcare benefit cost increases in 2002, 56% of employers say they will raise employee contributions by as much as or more than their expected cost increases. In addition, more than 70% of employers are considering benefit reductions or an increase in employee co-pays over the next 12 months, according to a survey released by Washington-based consulting firm Watson Wyatt Worldwide.
U.S. life expectancy increased in 2000
December 1st 2001Life expectancy for the U.S. population reached a record high of 76.9 years in 2000 as mortality declined for several leading causes of death, according to preliminary figures from a report released by the Centers for Disease Control and Prevention.
Vouchers: More Data, Fewer Dollars
November 1st 2001Sampling is a sales rep's foot in the door to doctors' offices and the quickest way to get products into consumers' hands. That's why reps handed out $5 billion worth of the freebies last year, spending 30 percent of companies' promotional budgets in the process. Despite that huge investment, few product managers can assess its impact on product inventory, consumer demand, prescription rates, or market share. But sampling's greatest failure is its inability to provide the healthcare industry with product-use or patient data.
AMA educates docs on gift guidelines
November 1st 2001The Chicago-based American Medical Association has launched an educational effort to raise awareness of ethical guidelines regarding promotional gifts from medical industry representatives. The 18-month initiative will target physicians, medical students and sales representatives from pharmaceutical, medical device and equipment companies, asking them to comply with guidelines published in the Journal of the American Medical Association in 1991 (see sidebar) by the AMA's Council on Ethical and Judicial Affairs.
Depression program costs little
November 1st 2001Researchers funded by the National Institute of Mental Health have found that an inexpensive program that trains primary care providers to work with patients and mental health specialists to diagnose and properly treat depression can reduce the time that participating patients spend clinically depressed. Over a two-year period, the program reduced the duration of participating patients' depression by well over a month. The training program cost less than $500 per depressed patient and increased the time that the depressed patients spent employed during that two-year period by about four work weeks.
PCPs rank top medical innovations
November 1st 2001High-tech scanning methods, such as magnetic resonance imaging, and innovations to treat cardiovascular disease were ranked as highly important to the care of patients in a survey of 225 primary care physicians published in Health Affairs (vol. 20, no. 5). At the bottom of the list was bone marrow transplant.